ActLight, the Swiss semiconductor IP provider focusing on the field of CMOS photonics, has signed a license agreement with a leading semiconductor company which intends to use its innovative sensing technology to fulfill the fast growing demand of the global healthcare market.
“Now that the COVID-19 pandemic is spreading throughout the globe, we are proud to offer our Dynamic PhotoDiode technology to the healthcare segment together with a prestigious semiconductor company. In these times of trouble we all need to join forces to exploit innovative technologies at the service of the impacted communities,” said Roberto Magnifico, Chief Commercial Officer at ActLight.
The company’s patented CMOS-based photonics technology allows the substantial improvement of the efficiency and accuracy of various light sensing applications, such as Time Of Flight (TOF) based range meters, vital signs monitoring, 3D/2D cameras and much more. ActLight operates in the Internet of Things (IoT) market, with a focus on mobile and wearable devices, healthcare/medtech, autonomous driving, drones ones and robotics.
